All Stories

  1. Machine learning–based prediction of Clavien–Dindo ≥ II complications after ureteroscopy
  2. Effects of a Novel Electric Oral Hygiene Device on Salivary Redox Status: A Preliminary Ex Vivo Study
  3. Pharmacoeconomics of high-cost therapies: real world challenges
  4. Salvage Treatment of Ventilator-Associated Pneumonia Using Sulbactam–Durlobactam in a Preterm Neonate: A Case Report
  5. Efficacy and Safety of Adding Electrolysis Device to Standard Methods of Maintaining Oral Hygiene in Patients with Fixed Orthodontic Appliance
  6. Emerging adverse event signals of new analgesic suzetrigine: a disproportionality analysis of the FAERS database
  7. Clinically significant interactions between drugs, microbiome, and sex
  8. Microbiome-driven PKs: addressing research gaps and shaping future directions beyond the narrative review
  9. Microbiome-driven PKs: redefining drug metabolism beyond Host enzymes
  10. Machine learning-based optimization of the prostate health index for prostate cancer detection
  11. Genetic polymorphism and pharmacokinetics/toxicokinetics of carbamazepine: A general review
  12. Analysis of signals for constipation among antidepressants: Using FDA adverse event reporting database
  13. Fever of unknown origin: cost of illness study
  14. Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend
  15. Enhancing the Prediction of Clinically Significant Prostate Cancer Through Feature Engineering
  16. Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence
  17. Clinical advances in investigational epilepsy treatments
  18. Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union
  19. A Case of Paradoxical Appetite Increase During Semaglutide Therapy
  20. Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review
  21. Factors Affecting Thyroid Volume in Children Aged 4 to 18 Years
  22. Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
  23. Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis
  24. Nonchemotherapy drug‐induced cytopenias: A cost‐of‐illness study using the microcosting methodology based on real‐world data
  25. Predictive clinical characteristics for adverse pathological outcomes in intermediate- and high-risk prostate cancer during biopsy
  26. Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia—An Inpatient Welfare Institution-Based Cross-Sectional Study
  27. Using validated model informed precision dosing for dose adjustment: superior evidence needed for efficacy and safety
  28. Clinical Pharmacokinetics and Pharmacodynamics of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
  29. 3D transesophageal echocardiography has benefits in the diagnosis and prognosis of patients with infectious endocarditis
  30. Preventable serious drug-disease interactions of reserve antibiotics
  31. Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models
  32. Risk factors for urinary tract infection and asymptomatic bacteriuria after stroke
  33. Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs
  34. Translation to Serbian and Transcultural Adaptation of the Fraboni Scale of Ageism in a Population of Community Pharmacists
  35. ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  36. Predicting intermediate-risk prostate cancer using machine learning
  37. Anthropometric Data by Using Bioelectrical Analysis as a Parameters for New Classification and Definition of Obesity
  38. Risk factors for severe adverse drug reactions in hospitalized patients
  39. Physiologically based pharmacokinetic and toxicokinetic modeling: A multidisciplinary approach to drug development and ecotoxicology
  40. Vitamin K epoxide reductase complex subunit 1 gene promoter polymorphism - a potential genetic basis for survival from thromboembolism in COVID-19
  41. Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures
  42. <em>ABCB1</em> Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  43. Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature
  44. New Scale Measuring Willingness to Deliver Pharmaceutical Care to Elderly (WPhCAReELD Scale)
  45. Novel Insights into Amlodipine-Induced Gingival Enlargement: A Clinical and Molecular Perspective
  46. Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults
  47. Predictors of Intrahospital Mortality in Aneurysmal Subarachnoid Hemorrhage after Endovascular Embolization
  48. Predictors Of Marketing Authorization Status Of Dipyrone Within A Country
  49. POPULATION PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS ON DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME
  50. Validation of Novel High-Performance Liquid Chromatography Method for Meropenem Quantification in Plasma
  51. Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
  52. Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions
  53. Factors Associated with Abnormal Uterine Bleeding in Perimenopausal Women
  54. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
  55. Multidisciplinary teams in healthcare
  56. Add-on antihypertensives for treatment of resistant hypertension: An extension of the TRYCORT study
  57. Antiobesity drugs utilization trend analysis and reimbursement lists status: The perspective of selected European countries
  58. Biomarkers of inflammation and multisystem tissue and organ damage in patients with COVID-19
  59. Diagnostic agreement of presepsin, procalcitonin, C-reactive protein and white blood cell count in patients with suspected sepsis
  60. Improving estimate of cost/effectiveness of drugs for rare diseases
  61. Patient blood management: Team working between clinical transfusiology and clinical pharmacology
  62. Population pharmacokinetics of vancomycin in hemodialysis patients
  63. Long-term outcomes in refractory status epilepticus
  64. Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
  65. Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis
  66. Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologists
  67. Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
  68. Enhanced PSA Density Prediction Accuracy When Based on Machine Learning
  69. Guidance for interactions between antiseizure medications
  70. Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
  71. Healing Factors of Decubital Lesions in Denture Wearers
  72. SGLT2 Inhibitors: A Systematic Review for Heart Failure Treatment
  73. Investigational new drugs for the treatment of Dravet syndrome: an update
  74. Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience
  75. Hypovitaminosis D in infants: Evidence that increased intake of vitamin D reduces the incidence of allergic and respiratory disorders
  76. Psychometric Properties of the Persian Version of Fear of Hospitalization Scale in Patients Undergoing Emergency Surgery
  77. Testing of new instrument for measuring quality and diversity of nutrition in pregnancy
  78. Acute toxicity threshold of normobaric oxygen therapy: Systematic review
  79. Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression
  80. Kounis Syndrome Associated With the Use of Diclofenac
  81. Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review
  82. Improved Prediction of Significant Prostate Cancer Following Repeated Prostate Biopsy by the Random Forest Classifier
  83. Meta‐analysis of peripheral insulin‐like growth factor 1 levels in schizophrenia
  84. Factors Associated with Potentially Inappropriate Prescribing in Patients on Peritoneal Dialysis
  85. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation
  86. Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review
  87. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review
  88. Advancements in neuroactive peptides in seizures
  89. Reduction of direct and indirect costs of treatment of patients with type 2 diabetes due to good glycemic control and reduced frequency of complications
  90. Risks factors of prolonged hospitalization in COVID-19 patients
  91. Toxic megacolon after irrational antibiotic treatment of pregnat patient with Covid 19: Case report
  92. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning
  93. Novel and emerging therapeutics for genetic epilepsies
  94. Antimicrobial treatment of Morganella morganii invasive infections: Systematic review
  95. Effects of Supplementation in Vitamin D3 Deficient or Insufficient Children with Allergic Diseases
  96. Personalization of drug dose thematic issue: introduction article
  97. Risk factors for potential drug–drug interactions in patients with myasthenia gravis
  98. Treating of focal epilepsy: a patent review
  99. <b>Quality of Life Assessment in Type 2 Diabetes Patients With Cardiovascular and/or Diabetic Complications</b>
  100. Does the Severity of Obstructive Sleep Apnea Have an Independent Impact on Systemic Inflammation?
  101. New instrument for measuring quality of life in patients with cervical cancer
  102. Characteristics of COPD Phenotypes in Serbia
  103. Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
  104. Inflated Co-authorship Introduces Bias to Current Scientometric Indices
  105. Accuracy of serum procalcitonin, C-reactive protein and soluble CD14 subtype levels in diagnosis of sepsis in children
  106. DRESS syndrome without eosinophilia induced by Carbamazepine: A case report
  107. Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU)
  108. Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
  109. Method for adjusting results of pharmacoeconomic studies from country to country using Bayesian statistics
  110. Risk factors for potential drug-drug interactions in a general neurology ward
  111. The QTc interval and treatment outcome of inpatients with COVID-19
  112. Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa
  113. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
  114. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  115. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance
  116. Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE
  117. Evaluation of zonisamide for the treatment of focal epilepsy: a review of pharmacokinetics, clinical efficacy and adverse effects
  118. Predictors of antibiotic utilization among intensive care unit patients
  119. Antiviral therapy of COVID-19
  120. Drug rash with eosinophilia and systemic symptoms syndrome in an adolescent - efficiency of immunoglobulin G in a corticosteroid resistant case
  121. Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
  122. Geopolitical thought in the Apennine peninsula: Teachers and students
  123. Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa
  124. Translation to Serbian and transcultural adaptation of the oral health-related quality of life [OHQoL-UK(W)] instrument
  125. The Basic Principles of Editing Biomedical Scientific Journals
  126. Correlation between laboratory parameters and COVID-19 treatment outcome
  127. Local guidelines for drug treatment of patients with COVID-19
  128. Surgical Fear Questionnaire (SFQ) - Serbian cultural adaptation
  129. The reasons for development of complications in soft contact lenses wearers: A qualitative study
  130. Editing Medical Journals B
  131. Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost–benefit ratios and prevalence
  132. Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy
  133. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization
  134. Contemporary surgical management of drug-resistant focal epilepsy
  135. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Plasmodium vivax malaria
  136. Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ)
  137. Antimicrobial treatment of Kocuria kristinae invasive infections: Systematic review
  138. Effects of local guidelines on prescribing practice and treatment outcomes in a long-stay psychiatric facility
  139. Pandrug-resistant Pseudomonas aeruginosa isolated from qualitative endotracheal aspirate could rather be contaminant than causative agent of respiratory infections in intensive care unit patients: Case study
  140. Predictors of potential drug-drug interactions in patients at intensive care unit
  141. Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
  142. Development and validation of a questionnaire for measuring drug-induced nausea
  143. Factors influencing extent of nausea in the patients on oral iron therapy
  144. Performance of a calculator for diagnosing the cause of liver damage
  145. Psychometric properties of the Headache Under-Response to Treatment (HURT) questionnaire and the Migraine Disability Assessment Test (MIDAS) translated to Serbian
  146. Where next for antiepileptic therapeutic drug monitoring?
  147. Antimicrobial Activity of Aqueous Extracts of Potentilla Reptans L. Rhizome and Aerial Part
  148. Drug–drug interactions in patients receiving hematopoietic stem cell transplantation
  149. Drug–drug interactions in patients with acute coronary syndrome across phases of treatment
  150. Pharmacokinetics of vancomycin in patients with different renal function levels
  151. Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review
  152. Investigational cannabinoids in seizure disorders, what have we learned thus far?
  153. Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections
  154. A questionnaire to measure how much a patient is afraid of being admitted to a hospital.
  155. A Questionnaire for Assessing Fear of Radiotherapy in Oncology Patients
  156. Delirium Risk Factors in Elderly Patients Suffering from Femoral Neck Fractures
  157. Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
  158. Analysing factors which influence treatment outcomes by multivariable linear regression
  159. Calculation of drug dose which produces 'all-or-nothing' response in 50% of subjects (effective dose 50) using probits
  160. The role of a pharmacist in prevention and detection of OTC drug interactions: Nominal group technique
  161. Modern approach to the therapy of infections caused by Clostridium difficile
  162. Risk factors for nosocomial infections in mechanically ventilated neonates at intensive care unit
  163. Alarm system for surveillance of patients receiving high doses of radioiodine (131I) therapy in the case of unauthorised abandoning of a controlled area
  164. The study of the Middle East in the Journal International Problems between 1950 and 1990
  165. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs
  166. Evaluation of brivaracetam: a new drug to treat epilepsy
  167. Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease
  168. Factors Influencing the Fear of Needles among Students of Medicine and Pharmacy
  169. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit
  170. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children
  171. Translation, Cultural Adjustment and Evaluation of Reliability and Validity of “Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form” for Patients with Schizophrenia
  172. Psychometric Development of Chemotherapy Side Effects Fear Scale
  173. Development and Validation of the Questionnaire for the Evaluation of Knowledge about Herbal Preparations (QEK-HP)
  174. Factors associated with the rate of COPD exacerbations that require hospitalization
  175. Antiepileptic potential of ganaxolone
  176. Translation to Serbian, cultural adaptation, reliability testing and validation of the questionnaire estimating the fear of injections
  177. Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis
  178. Clinical and laboratory parameters associated with death in acute pancreatitis
  179. Predictors of involuntary hospitalisation of patients suffering from schizophrenia
  180. Effects of antidepressants on serum concentrations of bone metabolism markers and major electrolytes in patients from routine psychiatric practice
  181. Hospital infections rate and health staff density in a Neonatology Department
  182. Translation to Serbian, Transcultural Adaptation and Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM- ICU)
  183. Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii
  184. Consulting clinical pharmacologist about treatment of inpatients in a tertiary hospital in Serbia
  185. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
  186. Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome
  187. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
  188. The psychometric properties of the Comprehensive Headache-related Quality of life Questionnaire (CHQQ) translated to Serbian
  189. The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry
  190. Effects of cardiovascular drugs on TSH serum levels in patients on replacement therapy after thyroidectomy
  191. Pharmacokinetics of linezolid in critically ill patients
  192. CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy
  193. Population Pharmacokinetics of Bisoprolol in Hemodialysis Patients with Hypertension
  194. Analysis of Treatment-Related Factors Affecting Mortality in Patients with Severe Necrotizing Acute Pancreatitis
  195. Hospital-Acquired Pneumonia in Newborns with Birth Weight Less Than 1500 Grams: Risk Factors and Causes
  196. Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
  197. Measuring Potential of Preschool Facility Staff to Prevent Early Childhood Caries
  198. Neutropenia induced by non-cytotoxic drugs
  199. Headache in patients undergoing general anesthesia
  200. Drug-related problems in patients with osteoporosis
  201. Frequency of headache in oncology patients undergoing radiotherapy
  202. Factors affecting inappropriate prescription of antibiotics and the emergence of antibiotic resistance in patients in primary health care
  203. Factors influencing knowledge transfer from faculty to PhD students
  204. Factors associated with early treatment failure in adult hospitalized patients with community-acquired pneumonia
  205. Markers of inflammation as risk predictors of lethal outcome in patients diagnosed with delirium
  206. Risk factors for healthcare-acquired urinary tract infections caused by multi-drug resistant microorganisms
  207. Etiology and resistance patterns of bacteria causing ventilator-associated pneumonia in a medical intensive care unit
  208. Parameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs
  209. Quality of life in patients early after surgery
  210. Neuroleptic malignant syndrome: the diagnostic dilemma
  211. Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs
  212. Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro
  213. The importance of early recognition and timely treatment of delirium in intensive care units
  214. Measuring Patientsʼ Knowledge About Adverse Effects of Angiotensin-Converting Enzyme Inhibitors
  215. Vectors of Turkish foreign policy: What remains of the strategy for 2023?
  216. P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration
  217. MANAGEMENT OF CLINICALLY CURED TONSILLOPHARYNGITIS IN PATIENTS WITH GROUP A STREPTOCOCCUS ISOLATED FROM A PHARYNGEAL SWAB
  218. IMPROVING ANTIPSYCHOTICS PRESCRIBING BY PHARMACEUTICAL CARE
  219. Risk factors for potentially inappropriate prescribing to older patients in primary care
  220. Epidemiology and Treatment Guidelines of Negative Symptoms in Schizophrenia in Central and Eastern Europe: A Literature Review
  221. Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter
  222. THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine
  223. Predictors of Length of Stay in Patients with Spinal Cord Injury
  224. The use of dry Jerusalem artichoke as a functional nutrient in developing extruded food with low glycaemic index
  225. Analiza efektywności kosztowej terapii dronedaronem w porównaniu z leczeniem amiodaronem, propafenonem i sotalolem w grupie chorych z migotaniem przedsionków: wyniki badania przeprowadzonego w Serbii
  226. Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach
  227. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
  228. Reasons for Inadequate Vaccination after Splenectomy
  229. Perifocal oedema after endovascular embolization
  230. Early Cytokine Profile Changes In Interstitial And Necrotic Forms Of Acute Pancreatitis
  231. CYP3A5 Polymorphism In Serbian Paediatric Epileptic Patients On Carbamazepine Treatment
  232. Risk Factors For Development Of Acute Necrotizing Pancreatitis
  233. Quality Of Life Among Patients With Depression
  234. Lack Of PRSS1 And SPINK1 Polymorphisms In Serbian Acute Pancreatitis Patients
  235. Treatment of hypokalemia
  236. Drug-induced immune thrombocytopenia
  237. Drug treatment and prevention of postoperative headache
  238. Prevention and treatment of postoperative vomiting
  239. Calcitonin Gene-Related Peptide Receptor Blocker Inhibits Spontaneous Activity of Human Ureter
  240. Transplantation through the ages
  241. Adjuvant drug therapy of bleeding from gastric or duodenal ulcer
  242. Costs of benign prostatic hyperplasia treatment in Montenegro
  243. Analysis of the costs of treating dry socket
  244. Cognitive status of persons under guardianship living in a social welfare institution
  245. Analysis of risk factors for occlusions of a synthetic femoropopliteal bypass graft
  246. Improving clinical drug development regulatory procedures for anticonvulsants
  247. Assessment of the reliability of the Serbian version of the sickness impact profile questionnaire in patients with chronic viral hepatitis
  248. Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome
  249. Cost-effectiveness of depressive episode pharmacological treatment
  250. Risk factors for the development of metabolic syndrome in obese children and adolescents
  251. Impact of educational intervention on prescribing inappropriate medication to elderly nursing homes residents
  252. Population pharmacokinetics of 25-hydroxyvitamin D in healthy young adults
  253. Health care–acquired infections in neonatal intensive care units: Risk factors and etiology
  254. Attitudes of PhD students towards qualitative research methods in medicine
  255. Interaction between tigecycline and human serum albumin in aqueous solution
  256. generic versus brand anticonvulsants
  257. Rational therapy publication rate correlates with wealth of a society
  258. Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition
  259. Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications
  260. Comparison of EMA and FDA guidelines for drug interactions: An overview
  261. Hypocalcaemia: Causes, diagnostics and treatment
  262. Prescribing Antipsychotics in Montenegro: a Focus Group Analysis
  263. Medical emergencies facing general practitioners: Drugs for the doctor's bag
  264. Prevalence and predictors of potential drug-drug interactions
  265. The effects of microwave radiation on microbial cultures
  266. The Influence of Antipsychotics on the Quality of Life of Patients with Schizophrenia in a Long-stay Psychiatric Facility
  267. Risk factors for severe dental anxiety among medical students
  268. Comparative analysis of the chemical composition and antimicrobal activities of some of Lamiaceae family species and Eucaliptus (Eucaliptus globules M)
  269. Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition
  270. Preparation, characterization and antimicrobial activity of chitosan microparticles with thyme essential oil
  271. Analysis of the Factors Influencing Functional Outcomes in Patients with Spinal Cord Injury
  272. Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium
  273. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: Sensitivity to antibiotics and risk factors
  274. Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilization
  275. Influence of dialysis modality and membrane flux on insomnia severity in haemodialysis patients
  276. The preclinical discovery and development of ezogabine for the treatment of epilepsy
  277. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia
  278. Population Pharmacokinetics of Carvedilol in Patients with Congestive Heart Failure
  279. Captopril May Influence Tone of Human Oviduct Ampulla
  280. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure
  281. PhD Students’ Awareness of Research Misconduct
  282. Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents
  283. Cushing’s syndrome diagnosed after delivery: a case report
  284. Adequate doctor - patient communication
  285. Population pharmacokinetic of antiepileptic drugs in different populations
  286. A report of a medication error: Drug incompatibility
  287. Cardiotoxicity of Palladium Compounds / Kardiotoksičnost Jedinjenja Paladijuma
  288. Submissiveness to health authorities as an obstacle to practicing evidence based medicine
  289. Profile of urinary tract infections pathogens and their antimicrobial resistance patterns during three-year period (2009-2011) in the Clinical center Kragujevac
  290. Rituximab for the treatment of rheumatiod arthritis patients with failure to the first biologic drug: Impact on Republic fund for health insurance in Serbia
  291. Zuclopenthixol decanoate in pregnancy: Successful outcomes in two consecutive off springs of the same mother
  292. Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study
  293. Comparative analysis of the chemical composition of Heliantus tuberosus L. growing in Serbia and Romania
  294. Comparison of three methods used for measurement of radioiodine fixation in thyroid gland of mice
  295. Hospital infections in a neurological intensive care unit: incidence, causative agents and risk factors
  296. Population pharmacokinetics of bisoprolol in patients with chronic heart failure
  297. Effects of aurothiomalate and gold(III) complexes on spontaneous motility of isolated human oviduct
  298. Online Remote Monitoring of Patients with Differentiated Thyroid Carcinomas and Neuroendocrine Tumors Treated with High Doses of Radionuclides
  299. Chemical and Antimicrobial Evaluation of Supercritical and Conventional Sideritis scardica Griseb., Lamiaceae Extracts
  300. Toxic Effects of Palladium Compounds on the Isolated Rat Heart
  301. Utilization of non-steroidal anti-inflammatory drugs in General and Endocrine Surgery Ward at Clinical Center 'Kragujevac' in Kragujevac
  302. Factors associated with hospitalization of children with acute odontogenic infections
  303. Factors associated with death in intensive care unit patients with ventilator-associated pneumonia
  304. Role of anticonvulsant therapeutic drug monitoring in improving clinical outcomes: An example of 12 adult epilepsy patients
  305. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  306. Demographic characteristics and functional outcomes in patients with traumatic and nontraumatic spinal cord injuries
  307. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  308. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  309. Predictors of pressure ulcers in patients with spinal cord injuries
  310. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  311. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  312. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  313. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects
  314. Changes of platelets’ function in preeclampsia
  315. N-acetyltransferase-2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population
  316. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis
  317. Gallbladder Emptying in Patients with Major Depression: A Case Series
  318. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care
  319. Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions
  320. Embolization of ruptured intracranial aneurysms with detachable coils: case series
  321. Effects of Methyldopa and Nifedipine on Uteroplacental and Fetal Hemodynamics in Gestational Hypertension
  322. Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
  323. Electrolyte disorders associated with risperidone in psychotic patients
  324. Quality of life in patients with multiple sclerosis
  325. Metabolic syndrome in children and adolescents
  326. Of the phytochemical research performed to date on sideritis species
  327. The methodology of determining antibacterial activity of plant extracts with disk-diffusion method in vitro
  328. Risk factors for early postoperative arrhythmias in general surgery patients after general anesthesia
  329. Differentiation between opiate addicts in relation to judicial problems
  330. Adverse events induced by anti-infectives in hospitalized patients
  331. Attitudes towards antipsychotic drugs and their side effects: A comparison between students of medicine in Spain and Serbia
  332. Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone
  333. Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women
  334. Non-invasive screening: The probability of events
  335. Resistance rates of Pseudomonas aeruginosa and Acinetobacter species causing ventilator-associated pneumonia do not always correlate with utilisation of antibiotics
  336. Risperidone-Associated Hypocalcemia
  337. Factors influencing valproate pharmacokinetics in children and adults
  338. Aliskiren and angioedema
  339. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
  340. Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
  341. In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population
  342. Pharmacokinetic modelling of valproate in epileptic patients
  343. Antihypertensive drugs utilisation and educational activities
  344. Risk factors for recurrent vulvovaginal candidiasis
  345. A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy
  346. The contractile effects of endothelins on isolated isthmic segment of human oviduct at the luteal phase of the menstrual cycle
  347. Monitoring of drug-associated electrolyte disturbances in a hospital
  348. Unexpected Effect of Furosemide on Radioiodine Urinary Excretion in Patients with Differentiated Thyroid Carcinomas Treated with Iodine 131
  349. Effects of Exogenous Glutamate and Kainate on Electric Field-stimulated Contractions of Isolated Human Ureter
  350. Costs of Rheumatoid Arthritis in a Balkan Country (Serbia)
  351. Renal transplantation vs hemodialysis: Cost-effectiveness analysis
  352. Significance of herbal drugs legislation for their rational use
  353. Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia
  354. Current clinical evidence on topiramate pharmacokinetics
  355. Cost-effectiveness of four immunomodulatory therapies for relapsingremitting multiple sclerosis: A Markov model based on data a Balkan country in socioeconomic transition
  356. Contractile effects of endothelins on isolated ampullar segment of human oviduct in luteal phase of menstrual cycle
  357. Effects of cisplatin and other Pt(II) complexes on spontaneous motility of isolated human oviduct
  358. Risk factors for treatment failure in renal suppurative infections
  359. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy
  360. Cost-Effectiveness of Ritodrine and Fenoterol for Treatment of Preterm Labor in a Low–Middle-Income Country: A Case Study
  361. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients
  362. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
  363. Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics
  364. Serum and Uterine Concentrations of Cefazolin, Cefuroxime, and Ceftriaxone After Intraoperative Prophylactic Administration During Cesarean Section
  365. Effect of exogenous glutamate and N-Methyl-D-aspartic acid on spontaneous activity of isolated human ureter
  366. Pathogenic mechanisms in the development of surgical site infections
  367. Clinical pharmacology in Serbia: The time for new challenges
  368. Drug utilisation patterns in Zabljak municipality, Serbia and Montenegro
  369. Pharmacokinetic modelling of valproate from clinical data in Serbian epileptic patients
  370. Middle East conflicts: Basic features
  371. Inhibitory effects of selected antiepileptics on spontaneous motility of isolated human oviducts
  372. Characteristics of decision-making process during prescribing in general practice
  373. National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
  374. Prevention of spreading of avian influenza in medical care facilities
  375. Impact of clinical pharmacology on health care: Serbian experience
  376. Population pharmacokinetics
  377. Clinical pharmacology in health care service
  378. Renal Adverse Effects of Interferon-??
  379. Effect of the exogenous glutamate and the NMDA on electric field-stimulated contractions of isolated rat ileum
  380. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country
  381. Osnovi glutamatergicke neurotransmisije
  382. Mere za unapredjenje lekarske prakse
  383. Farmakologija receptora i celijskih transportera za glutamat
  384. Contractile effect of acetylcholine on isolated isthmic segment of fallopian tubes
  385. Contractile effect of acetylcholine on isolated ampullar segment of fallopian tubes
  386. Semi-Intensive Versus Intensive Monitoring of Adverse Drug Reactions in a Hospital
  387. Comparison of efficacy and safety between individualized and empiric dose regimen of amitriptyline in the treatment of major depressive episode
  388. Stimulating Spontaneous Reporting of Adverse Drug Reactions by a Patient
  389. Effect of intratumoral application of methotrexate in vivo on frequency of micronuclei in peripheral blood lymphocytes
  390. Slobodan Jankovic
  391. Whether use of antipsychotics in psychogeriatric facilities is appropriate?
  392. A pharmacological analysis of the contractile effects of glutamate on rat and human isolated gut smooth muscle strips
  393. Antipsychotic Drug Prescription in a Serbian Long-Stay Psychiatric Care Facility
  394. EFFECTS OF NICOTINE, DIMETHYLPHENYLPIPERAZINIUM AND TETRAMETHYLAMMONIUM ON SMOOTH MUSCLES FROM FELINE AND HUMAN GASTRIC CORPUS
  395. THE EFFECTS OF EXCITATORY AMINO ACIDS ON ISOLATED GUT SEGMENTS OF THE RAT
  396. A study of the effect of benzylpenicillin on isolated human gallbladder
  397. The control of hair growth
  398. DIFFERENCES IN THE EFFECTS OF VASOPRESSIN AND OXYTOCIN ON FELINE GASTRIC CORPUS MOTILITY: SELECTIVE ACTION OF VASOPRESSIN ON LONGITUDINAL MUSCLE